Skip to main content
. Author manuscript; available in PMC: 2012 Jul 29.
Published in final edited form as: Circ Heart Fail. 2011 May 3;4(4):425–432. doi: 10.1161/CIRCHEARTFAILURE.111.961326

Table 5.

Phosphorylation levels of sarcomeric proteins in patients with nonischemic cardiomyopathy before and after LVAD implantation.

Before LVAD After LVAD P-value* Nonfailing
Myosin Binding Protein C 6.1 ± 1.2 6.7 ± 1.0 0.328 4.6 ± 0.6
Troponin T 19.2 ± 3.0 18.0 ± 3.8 0.562 20.9 ± 7.0
Troponin I 12.8 ± 4.1 21.6 ± 9.4 0.030 13.2 ± 1.9
Tropomyosin 7.9 ± 2.6 8.5 ± 2.9 0.431 8.0 ± 1.9
Regulatory Myosin Light Chain 0.5 ± 0.2 0.7 ± 0.3 0.109 0.6 ± 0.2
Serine 22,23 phosphorylated Troponin I 3.7 ± 2.3 3.4 ± 1.5 0.747 2.8 ± 0.6
Serine 43 phosphorylated Troponin I 7.5 ± 2.2 5.2 ± 1.9 0.044 12.0 ± 1.0

Phosphorylation levels expressed in arbitrary optical density units.

*

P-value for comparison between Before LVAD and After LVAD

P<0.01 for comparisons of Myosin Binding Protein C between Before LVAD vs. Nonfailing and After LVAD vs. Nonfailing

P<0.001 for comparisons of Serine 43 phosphorylated Troponin I between Before LVAD vs. Nonfailing and After LVAD vs. Nonfailing